Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


The Cellulite Treatment Market is Predict to reach USD 5.4 Billion by 2031, at a CAGR of 10.1%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Cellulite Treatment Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Cellulite Treatment Market size is expected to reach $5.4 billion by 2031, rising at a market growth of 10.1% CAGR during the forecast period.

The Female segment is registering a strong potential in the Global Cellulite Treatment Market by Gender in 2023 thereby, achieving a market value of $4 Billion by 2031. Cellulite affects up to 90% of women at some point, typically appearing on the thighs, buttocks, and abdomen. As a result, there is a strong demand for effective cellulite treatments among women seeking to improve the appearance of their skin. Additionally, many women view cellulite as a cosmetic concern that can impact their confidence and body image, driving them to seek out solutions to reduce its appearance. Women are also more likely to seek out cellulite treatments due to the influence of media and advertising.

Cellulite Treatment Market Size - By Region

The Topical segment is poised to have a CAGR of 10.2% during (2024 - 2031). It is possible to apply topical cellulite treatments at home, which makes them a convenient option for people who lead busy lifestyles because they are simple to use and can be applied at home. Moreover, they are widely available over the counter or online, making them easily accessible to consumers without needing a prescription or medical supervision. Topical cellulite treatments can be used with other cellulite reduction methods, such as diet and exercise, to enhance results and improve the skin's overall appearance.

The Soft Cellulite segment is leading Global Cellulite Treatment Market by Cellulite Type in 2023 thereby, achieving a market value of $2.5 Billion by 2031. Soft cellulite is typically found in areas with thicker skin, such as the buttocks and thighs, and is often caused by genetics, hormonal changes, and lifestyle habits. Treatment options for soft cellulite may include both non-invasive and minimally invasive procedures. The demand for soft cellulite treatments is driven by several factors, including increasing awareness and acceptance of aesthetic procedures, changing beauty standards, and technological advancements that have made treatments more effective and accessible.

The Hospitals segment is anticipated to have a CAGR of 10.3% during (2024 - 2031). In hospitals, cellulite treatment may be provided by dermatologists, plastic surgeons, or other healthcare professionals with expertise in skin and body treatments. Hospitals that offer cellulite treatment may use a variety of approaches, including non-invasive procedures, minimally invasive procedures, and surgical treatments, depending on the severity of the cellulite and the patient's individual needs. Patients receiving cellulite treatment at a hospital can benefit from the expertise of healthcare professionals and the resources of a medical facility dedicated to providing quality care.

Full Report: https://www.kbvresearch.com/cellulite-treatment-market/

The North America region dominated the Global Cellulite Treatment Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2.4 Billion by 2031. The Europe region would witness a CAGR of 9.9% during (2024 - 2031). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2024 - 2031).

List of Key Companies Profiled

  • Candela Corporation (Syneron Medical)
  • Bausch Health Companies, Inc.
  • Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
  • AbbVie, Inc.
  • Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
  • Hologic, Inc.
  • Galderma S.A.
  • Zimmer MedizinSysteme GmbH
  • Endo International PLC
  • Merz Pharma GmbH & Co. KGaA

Cellulite Treatment Market Report Segmentation

By Gender

  • Female
  • Male

By Procedure Type

  • Non-invasive
  • Topical
  • Minimally Invasive

By Cellulite Type

  • Soft Cellulite
  • Hard Cellulite
  • Edematous

By End User

  • Clinics & Beauty Centers
  • Hospitals
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Related Reports:



SUBSCRIPTION MODEL